All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.
During COMy 2020, Mohamad Mohty, Saint-Antoine Hospital and Sorbonne University, Paris, FR, discussed highlights from the first virtual COMy meeting.
Professor Mohty outlined the controversial debates that took place during the virtual meeting. Debate topics included the treatment of elderly patients with multiple myeloma, the prognostic value of minimal residual disease to guide treatment decisions, and the routine incorporation of anti-CD38 monoclonal antibodies into induction regimens. A hot topic of the COMy 2020 online meeting was the question of whether or not to proceed with transplant, and professor Mohty concluded with a personal opinion on the matter.
Highlights from the first virtual COMy meeting
The value of MRD in multiple myeloma
Mohamad Mohty, Saint-Antoine Hospital and Sorbonne University, Paris, FR, discusses the value of minimal residual disease (MRD) in multiple myeloma (MM).
EHA 2019 | Highlights in newly diagnosed multiple myeloma
Mohamad Mohty from the Hôpital Saint-Antoine, Paris, FR, talks about the role of autologous stem cell transplant (ASCT) in the future treatment of multiple myeloma (MM).
Subscribe to get the best content related to multiple myeloma delivered to your inbox